Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:312-317

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, D. N.
Right arrow Articles by Luft, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, D. N.
Right arrow Articles by Luft, F. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Hypertension. 1999;33:312-317.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Effects of Human Prorenin in Rats Transgenic for Human Angiotensinogen

Dominik N. Müller; Karl F. Hilgers; Salima Mathews; Volker Breu; Walter Fischli; Regina Uhlmann; Friedrich C. Luft

From the Franz Volhard Clinic at the Max Delbrück Center for Molecular Medicine, Medical Faculty of the Charité, Humboldt University of Berlin (D.N.M., R.U., F.C.L.) and the University of Erlangen-Nürnberg (K.F.H.), Germany; and Hoffmann-La Roche (S.M., V.B.) and Actelion (W.F.), Basel, Switzerland.

Correspondence to Friedrich C. Luft, MD, Franz Volhard Clinic, Wiltberg Strasse 50, 13122 Berlin, Germany. E-mail luft{at}fvk-berlin.de

Abstract—The physiological role of prorenin is unknown; however, the possibility that prorenin inhibits renin locally has been suggested. We tested the hypothesis that prorenin may be an endogenous competitor for renin uptake in the tissue. We also investigated whether prorenin can be activated to active renin and affect mean arterial pressure (MAP). Isolated perfused hindquarters of rats transgenic for human angiotensinogen were infused with human renin and/or prorenin. The plateau phase of angiotensin (Ang) I release 15 minutes after cessation of infusions was used as a parameter for renin uptake. Renin (10 ng/mL for 15 minutes) caused sustained release of Ang I (153±16 fmol/mL). Coinfusion with a 15-fold excess of prorenin did not affect local Ang I formation (153±19 fmol/mL). Prorenin infusion alone showed no activation to active renin. In addition, we investigated MAP and plasma Ang II levels after injection of saline ({Delta}MAP, -1±2 mm Hg; 40±5 fmol/mL Ang II), 9 ng renin ({Delta}MAP, +37±3 mm Hg; 378±39 fmol/mL), and 144 ng prorenin ({Delta}MAP, +10±5 mm Hg; 61±5 fmol/mL) and the coinjection of renin and prorenin ({Delta}MAP, +41±4 mm Hg; 305±23 fmol/mL) in anesthetized rats. The data show that prorenin was not activated to active renin and did not affect MAP in short-term experiments. Renin-induced Ang formation was not affected by prorenin. Renin may have been taken up specifically because of its physical and chemical properties or because of nonspecific sequestration in the extravascular space. We conclude that prorenin does not act as an endogenous antagonist for the long-lasting effects of renin in the vascular wall. Moreover, prorenin does not affect acute renin-related effects on blood pressure.


Key Words: rats, transgenic • angiotensinogen • angiotensin • prorenin • renin • hindlimbs




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Zhang, N. A. Noble, W. A. Border, R. T. Owens, and Y. Huang
Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E810 - E819.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Campbell
Critical Review of Prorenin and (Pro)renin Receptor Research
Hypertension, May 1, 2008; 51(5): 1259 - 1264.
[Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
D. N Muller and F. C Luft
Effects of human prorenin in rats transgenic for human angiotensinogen revisited
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2008; 9(1_suppl): S4 - S5.
[PDF]


Home page
HypertensionHome page
A.H. J. Danser and J. Deinum
Renin, Prorenin and the Putative (Pro)renin Receptor
Hypertension, November 1, 2005; 46(5): 1069 - 1076.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. Peters, R. Farrenkopf, S. Clausmeyer, J. Zimmer, S. Kantachuvesiri, M. G.F. Sharp, and J. J. Mullins
Functional Significance of Prorenin Internalization in the Rat Heart
Circ. Res., May 31, 2002; 90(10): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. F. Hilgers, R. Veelken, D. N. Muller, H. Kohler, A. Hartner, S. R. Botkin, C. Stumpf, R. E. Schmieder, and R. A. Gomez
Renin Uptake by the Endothelium Mediates Vascular Angiotensin Formation
Hypertension, August 1, 2001; 38(2): 243 - 248.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. M. E. D. van den Eijnden, J. J. Saris, R. J. A. de Bruin, E. de Wit, W. Sluiter, T. L. Reudelhuber, M. A. D. H. Schalekamp, F. H. M. Derkx, and A. H. J. Danser
Prorenin Accumulation and Activation in Human Endothelial Cells : Importance of Mannose 6-Phosphate Receptors
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 911 - 916.
[Abstract] [Full Text] [PDF]